超声引导经翼腭窝上颌神经阻滞技术路径综述
本文综述2009至2019年文献,比较超声引导经翼腭窝行三叉神经分支阻滞的三种主要入路:前路颧下平面内、后路颧下平面内及颧上平面外。尸体、成人及儿科患者中均显示注射物扩散至翼腭窝,注射容量3至5 mL或0.15 mL/kg,理想入路尚未确定。
要点
- 经翼腭窝超声引导三叉神经分支阻滞主要有前路颧下、后路颧下及颧上三种入路
- 各入路在尸体、成人和儿科患者中均显示注射物扩散至翼腭窝
- 注射容量范围为3至5 mL或0.15 mL/kg,理想入路尚待进一步研究
核心结论
- 翼腭窝是超声引导上颌神经阻滞的易达靶点,共有三种主要入路,但理想入路尚未确定,需进一步探索。
研究设计与样本
- 文献综述,检索PubMed、Cochrane系统评价数据库和Google Scholar 2009年1月至2019年3月英文文献,最终纳入6篇:1项前瞻性双盲随机对照试验、1项前瞻性描述性研究、1项病例系列、2篇病例报告和1项尸体研究。
主要发现
- 三种主要入路为前路颧下平面内、后路颧下平面内和颧上平面外。
- 每种入路分别在尸体、成人患者和儿科患者中显示注射物扩散至翼腭窝。
- 所用注射容量从3至5 mL到0.15 mL/kg不等。
关键数值与推荐
- 注射容量范围:3至5 mL或0.15 mL/kg。
临床怎么用
- 临床可经前路颧下平面内、后路颧下平面内或颧上平面外入路行超声引导翼腭窝上颌神经阻滞,注射容量可参考3至5 mL或0.15 mL/kg。
局限性
- 纳入研究仅6篇,设计异质(含病例报告和尸体研究),理想入路尚未确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Blockade of the trigeminal nerve and its branches is an effective diagnostic tool and potential treatment of facial pain. Ultrasound-guided injections in the pterygopalatine fossa (PPF) to block the trigeminal nerve divisions and sphenopalatine ganglion have been described but a consensus has yet to be reached over the ideal approach. We sought to delineate and compare the various approaches to the ultrasound-guided trigeminal divisions blockade via the PPF. METHODS: The literature search was performed by searching the National Library of Medicine's PubMed database, the Cochrane Database of Systematic Reviews and Google Scholar within the date range of January 2009-March 2019 for keywords targeted toward "trigeminal nerve," "maxillary nerve," or "pterygopalatine fossa," "ultrasound," and "nerve block," using an English language restriction. Six papers were included in the final review: one prospective double-blinded randomized controlled trial, one prospective descriptive study, one case series, two case reports, and one cadaveric study. RESULTS: There are three main approaches to the ultrasound-guided trigeminal nerve branches blockade via the PPF: anterior infrazygomatic in-plane, posterior infrazygomatic in-plane, and suprazygomatic out-of-plane approaches. Each showed injectate spread to the PPF in cadaver, adult and pediatric patients, respectively.1-5 Injectate used varied from 3 to 5 mL to 0.15 mL/kg. CONCLUSIONS: These studies demonstrated that the PPF is a readily accessible target for the ultrasound-guided maxillary nerve block via three main approaches.2 The ideal approach is yet to be determined and must be further explored.
引用
- Anugerah A, Nguyen K, Nader A, et al. Technical considerations for approaches to the ultrasound-guided maxillary nerve block via the pterygopalatine fossa: a literature review. Reg Anesth Pain Med. 2020. PMID: 31924742. doi:10.1136/rapm-2019-100569
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。